Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Liver cancer statistics
New cases of liver cancer, 2015, UK
Deaths from liver cancer, 2014, UK
Preventable cases of liver cancer, UK
- There are around 5,700 new liver cancer cases in the UK every year, that's 16 every day (2013-2015).
- Liver cancer is the 18th most common cancer in the UK, accounting for 2% of all new cancer cases (2015).
- In males in the UK, liver cancer is the 15th most common cancer, with around 3,700 new cases in 2015.
- In females in the UK, liver cancer is the 20th most common cancer, with around 2,100 new cases in 2015.
- Incidence rates for liver cancer in the UK are highest in people aged 85 to 89 (2013-2015).
- Since the early 1990s, liver cancer incidence rates have increased by around two-and-a-half times (151%) in the UK. Rates in males have increased by around two-and-a-half times (152%), and rates in females have increased by more than two times (132%).
- Over the last decade, liver cancer incidence rates have increased by almost two-thirds (63%) in the UK. Rates in males have increased by around two-thirds (65%), and rates in females have increased by more than half (53%).
- Most liver cancers occur in the liver cells and the intrahepatic bile ducts.
- Incidence rates for liver cancer are projected to rise by 38% in the UK between 2014 and 2035, to 15 cases per 100,000 people by 2035.
- 1 in 105 men and 1 in 195 women will be diagnosed with liver cancer during their lifetime.
- Liver cancer in England is more common in males living in the most deprived areas. There is no association for females.
- Liver cancer is more common in Asian and Black people than White people.
- An estimated 5,000 people who had previously been diagnosed with liver cancer were alive in the UK at the end of 2010.
- In Europe, around 63,500 new cases of liver cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 14th lowest in Europe for males and 17th lowest for females.
- Worldwide, more than 782,000 people were estimated to have been diagnosed with liver cancer in 2012, with incidence rates varying across the world.
- There were around 5,100 liver cancer deaths in the UK in 2014, that’s 14 deaths every day.
- Liver cancer is the ninth most common cause of cancer death in the UK (2014).
- Liver cancer accounts for 3% of all cancer deaths in the UK (2014).
- In males in the UK, liver cancer is the seventh most common cause of cancer death, with around 3,100 deaths in 2014.
- In females in the UK, liver cancer is the 10th most common cause of cancer death, with around 2,000 deaths in 2014.
- Around half (49%) of liver cancer deaths in the UK each year are in people aged 75 and over (2012-2014).
- Mortality rates for liver cancer in the UK are highest in people aged 85-89 (2012-2014).
- Since the early 1970s, liver cancer mortality rates have increased by almost three-fold (196%) in the UK. The increase is similar in males (189% increase), and females (186% increase).
- Over the last decade, liver cancer mortality rates have increased by almost three-fifths (56%) in the UK, however this includes a larger increase in females (59%) than in males (53%).
- Mortality rates for liver cancer are projected to rise by 58% in the UK between 2014 and 2035, to 16 deaths per 100,000 people by 2035.
- Liver cancer deaths in England are more common in people living in the most deprived areas.
- In Europe, around 62,200 people were estimated to have died from liver cancer in 2012. The UK mortality rate is 11th lowest in Europe for males and 17th lowest for females.
- Worldwide, an estimated 745,000 people were estimated to have died from liver cancer in 2012, with mortality rates varying across the world.
- Around a quarter of people in England diagnosed with liver cancer aged 15-39 survive their disease for five years or more, compared with around 5 in 100 people diagnosed aged 80 and over (2009-2013).
- Five-year relative survival for liver cancer in men is below the European average in England and Scotland but similar to the European average in Wales and Northern Ireland.
- Five-year relative survival for liver cancer in women is below the European average in England and Scotland but similar to the European average in Wales.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 42% (49% in males and 28% in females) of liver cancer cases each year in the UK are linked to major lifestyle and other risk factors.
- An estimated 42% of liver cancer cases in the UK are linked to lifestyle factors including smoking (23%), infections (16%), and alcohol (9%).
- Oral contraceptives, some types of ionising radiation, and certain occupational exposures cause liver cancer.
- Fruit may relate to lower liver cancer risk, but evidence is unclear.
- Overweight and obesity, and certain medical conditions, may relate to higher liver cancer risk.
- 'Emergency presentation' is the most common route to diagnosing liver cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for upper gastrointestinal cancers.
- 20% of patients diagnosed with liver cancer have surgery to remove the tumour as part of their primary cancer treatment.
- 4% of patients diagnosed with liver cancer have surgery to remove the tumour as part of their primary cancer treatment.
- 24% of patients diagnosed with liver cancer have chemotherapy as part of their primary cancer treatment.
The latest statistics available for liver cancer in the UK are; incidence 2015, mortality 2014 and survival 2009-2013 (by age). Reliable survival data for trends over time in the UK is not available.
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012 for males and 2010-2012 for females due to the small number of cases.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Liver cancer is part of the group 'Upper Gastrointestinal cancer' for cancer waiting times data. Codes vary per country but broadly include: oesophagus, stomach, liver, gallbladder, other and unspecified parts of biliary tract, pancreas, secondary cancers of liver, intrahepatic bile duct and duodenum.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.